TAX-86498-59102
3 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 201 / VA
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-21
Registered in v-safe
-
2021-06-21
Dose 1 — Pfizer-BioNTech
-
2021-06-21
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-06-22
- 2021-06-23
- 2021-06-24
- 2021-06-26
- 2021-06-28
- 2021-07-06
-
2021-07-12
Dose 2 — Pfizer-BioNTech
- 2021-07-12
-
2021-07-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-26
- 2021-08-02
- 2021-08-09
- 2021-08-17
- 2021-08-23
- 2021-10-11
-
2022-01-10
Survey response — 6 months, dose 2MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, cough and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Dose 3 — Pfizer-BioNTech
- 2022-05-11
- 2022-08-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-21 | Pfizer-BioNTech | No |
| 2 | 2021-07-12 | Pfizer-BioNTech | No |
| 3 | 2022-02-08 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Sore throat, cough and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release